The therapeutic effect of GLP-1 on MASH is thought to be due to a reduction in body weight caused by a decrease in appetite and insulin resistance, which leads to an improvement in dyslipidemia and hepatic inflammation 33,34
(EtherPC-1 n = 14 metabolites, EtherPC-2 n = 90 metabolites, EtherPE-1 n = 58 metabolites, EtherPE-2 n = 67 metabolites, FA-1 n = 15 metabolites, FA-2 n = 29 metabolites, PC-1 n = 62 metabolites, PC-2 n = 51 metabolites, PG-1 n = 55 metabolites, PG-2 n = 45 metabolites, TG-1 n = 10 metabolites, TG-2 n = 96 metabolites)
Kidney Caution is advised in patients with kidney impairment, especially due to the presence of tranexamic acid, which may accumulate in severe kidney dysfunction
Ozempic should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency
With proper medical support, people can see safe and lasting results
Stunkard AJ, Srensen TI, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, et al
